Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder

F. Andrew Kozel, Uma Rao, Hanzhang Lu, Paul A. Nakonezny, Bruce Grannemann, Tamara McGregor, Paul E. Croarkin, Kimberly S. Mapes, Carol A. Tamminga, Madhukar H. Trivedi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Identifying biosignatures to assess the probability of response to an antidepressant for patients with major depressive disorder (MDD) is critically needed. Functional connectivity MRI (fcMRI) offers the promise to provide such a measure. Previous work with fcMRI demonstrated that the correlation in signal from one region to another is a measure of functional connectivity. In this pilot work, a baseline non-task fcMRI was acquired in 14 adults with MDD who were free of all medications. Participants were then treated for 8 weeks with an antidepressant and then clinically re-evaluated. Probabilistic anatomic regions of interest (ROI) were defined for 16 brain regions (eight for each hemisphere) previously identified as being important in mood disorders. These ROIs were used to determine mean time courses for each individual's baseline non-task fcMRI. The correlations in time courses between 16 brain regions were calculated. These calculated correlations were considered to signify measures of functional connectivity. The degree of connectivity for each participant was correlated with treatment outcome. Among 13 participants with 8 weeks follow-up data, connectivity measures in several regions, especially the subcallosal cortex, were highly correlated with treatment outcome. These connectivity measures could provide a means to evaluate how likely a patient is to respond to an antidepressant treatment. Further work using larger samples is required to confirm these findings and to assess if measures of functional connectivity can be used to predict differential outcomes between antidepressant treatments.

Original languageEnglish (US)
Article numberArticle 7
JournalFrontiers in Psychiatry
Volume2
Issue numberMAR
DOIs
StatePublished - 2011

Fingerprint

Major Depressive Disorder
Antidepressive Agents
Magnetic Resonance Imaging
Brain
Mood Disorders
Therapeutics

Keywords

  • Antidepressant
  • Connectivity
  • Functional MRI
  • Major depressive disorder
  • Non-task fcmri
  • Treatment prediction

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. / Andrew Kozel, F.; Rao, Uma; Lu, Hanzhang; Nakonezny, Paul A.; Grannemann, Bruce; McGregor, Tamara; Croarkin, Paul E.; Mapes, Kimberly S.; Tamminga, Carol A.; Trivedi, Madhukar H.

In: Frontiers in Psychiatry, Vol. 2, No. MAR, Article 7, 2011.

Research output: Contribution to journalArticle

@article{3b1449fc47494b919ee80bc4fbeb8800,
title = "Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder",
abstract = "Identifying biosignatures to assess the probability of response to an antidepressant for patients with major depressive disorder (MDD) is critically needed. Functional connectivity MRI (fcMRI) offers the promise to provide such a measure. Previous work with fcMRI demonstrated that the correlation in signal from one region to another is a measure of functional connectivity. In this pilot work, a baseline non-task fcMRI was acquired in 14 adults with MDD who were free of all medications. Participants were then treated for 8 weeks with an antidepressant and then clinically re-evaluated. Probabilistic anatomic regions of interest (ROI) were defined for 16 brain regions (eight for each hemisphere) previously identified as being important in mood disorders. These ROIs were used to determine mean time courses for each individual's baseline non-task fcMRI. The correlations in time courses between 16 brain regions were calculated. These calculated correlations were considered to signify measures of functional connectivity. The degree of connectivity for each participant was correlated with treatment outcome. Among 13 participants with 8 weeks follow-up data, connectivity measures in several regions, especially the subcallosal cortex, were highly correlated with treatment outcome. These connectivity measures could provide a means to evaluate how likely a patient is to respond to an antidepressant treatment. Further work using larger samples is required to confirm these findings and to assess if measures of functional connectivity can be used to predict differential outcomes between antidepressant treatments.",
keywords = "Antidepressant, Connectivity, Functional MRI, Major depressive disorder, Non-task fcmri, Treatment prediction",
author = "{Andrew Kozel}, F. and Uma Rao and Hanzhang Lu and Nakonezny, {Paul A.} and Bruce Grannemann and Tamara McGregor and Croarkin, {Paul E.} and Mapes, {Kimberly S.} and Tamminga, {Carol A.} and Trivedi, {Madhukar H.}",
year = "2011",
doi = "10.3389/fpsyt.2011.00007",
language = "English (US)",
volume = "2",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder

AU - Andrew Kozel, F.

AU - Rao, Uma

AU - Lu, Hanzhang

AU - Nakonezny, Paul A.

AU - Grannemann, Bruce

AU - McGregor, Tamara

AU - Croarkin, Paul E.

AU - Mapes, Kimberly S.

AU - Tamminga, Carol A.

AU - Trivedi, Madhukar H.

PY - 2011

Y1 - 2011

N2 - Identifying biosignatures to assess the probability of response to an antidepressant for patients with major depressive disorder (MDD) is critically needed. Functional connectivity MRI (fcMRI) offers the promise to provide such a measure. Previous work with fcMRI demonstrated that the correlation in signal from one region to another is a measure of functional connectivity. In this pilot work, a baseline non-task fcMRI was acquired in 14 adults with MDD who were free of all medications. Participants were then treated for 8 weeks with an antidepressant and then clinically re-evaluated. Probabilistic anatomic regions of interest (ROI) were defined for 16 brain regions (eight for each hemisphere) previously identified as being important in mood disorders. These ROIs were used to determine mean time courses for each individual's baseline non-task fcMRI. The correlations in time courses between 16 brain regions were calculated. These calculated correlations were considered to signify measures of functional connectivity. The degree of connectivity for each participant was correlated with treatment outcome. Among 13 participants with 8 weeks follow-up data, connectivity measures in several regions, especially the subcallosal cortex, were highly correlated with treatment outcome. These connectivity measures could provide a means to evaluate how likely a patient is to respond to an antidepressant treatment. Further work using larger samples is required to confirm these findings and to assess if measures of functional connectivity can be used to predict differential outcomes between antidepressant treatments.

AB - Identifying biosignatures to assess the probability of response to an antidepressant for patients with major depressive disorder (MDD) is critically needed. Functional connectivity MRI (fcMRI) offers the promise to provide such a measure. Previous work with fcMRI demonstrated that the correlation in signal from one region to another is a measure of functional connectivity. In this pilot work, a baseline non-task fcMRI was acquired in 14 adults with MDD who were free of all medications. Participants were then treated for 8 weeks with an antidepressant and then clinically re-evaluated. Probabilistic anatomic regions of interest (ROI) were defined for 16 brain regions (eight for each hemisphere) previously identified as being important in mood disorders. These ROIs were used to determine mean time courses for each individual's baseline non-task fcMRI. The correlations in time courses between 16 brain regions were calculated. These calculated correlations were considered to signify measures of functional connectivity. The degree of connectivity for each participant was correlated with treatment outcome. Among 13 participants with 8 weeks follow-up data, connectivity measures in several regions, especially the subcallosal cortex, were highly correlated with treatment outcome. These connectivity measures could provide a means to evaluate how likely a patient is to respond to an antidepressant treatment. Further work using larger samples is required to confirm these findings and to assess if measures of functional connectivity can be used to predict differential outcomes between antidepressant treatments.

KW - Antidepressant

KW - Connectivity

KW - Functional MRI

KW - Major depressive disorder

KW - Non-task fcmri

KW - Treatment prediction

UR - http://www.scopus.com/inward/record.url?scp=84862825490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862825490&partnerID=8YFLogxK

U2 - 10.3389/fpsyt.2011.00007

DO - 10.3389/fpsyt.2011.00007

M3 - Article

C2 - 21556277

AN - SCOPUS:84862825490

VL - 2

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

SN - 1664-0640

IS - MAR

M1 - Article 7

ER -